Breaking News
January 17, 2019 - Educational videos in clinical settings increase HPV vaccination rates among adolescents
January 17, 2019 - Better understanding of aggressive brain tumour
January 17, 2019 - Why is life expectancy in the U.S. going down? A Q&A
January 17, 2019 - The Electronics Industry Sees Money In Your Health
January 17, 2019 - Hypertension drug may improve effectiveness of ovarian cancer treatment
January 17, 2019 - Scientists reveal key mechanism in worms that controls cell’s response to stress
January 17, 2019 - How Patch Clamp Technology Can Benefit Ion Channel Research
January 16, 2019 - Researchers cultivate organoids that perfectly mimic blood vessels
January 16, 2019 - Sound Pharmaceuticals Advances Phase 2 Hearing Loss Clinical Trial in Cystic Fibrosis
January 16, 2019 - Unraveling the genetic causes of skin cancer
January 16, 2019 - Higher percentages of saturated fat in low-carb diets may not harm cholesterol levels, new analysis suggests
January 16, 2019 - Using bottled or tap water impacts health benefits of green tea
January 16, 2019 - Best trained alert dogs have potential to improve Type 1 diabetes patients’ quality of life
January 16, 2019 - States with lower incidence of melanoma have higher mortality rates
January 16, 2019 - Pollution on the London Underground found to be dangerously high
January 16, 2019 - Breast cancer cells in mice coaxed to turn into harmless fat cells
January 16, 2019 - Study connects the genetic background of autistic spectrum disorders with stem cell dysfunction
January 16, 2019 - When activated, ‘social’ brain circuits inhibit feeding behavior in mice | News Center
January 16, 2019 - How Exercise May Help Keep Our Memory Sharp
January 16, 2019 - Researchers identify a key regulator that stops excessive inflammation
January 16, 2019 - TGF-beta signaling pathway in uterine cells protects against cancer
January 16, 2019 - MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials
January 16, 2019 - Drug Repurposing May Provide More Psychiatric Tx Options
January 16, 2019 - A new brain imaging study challenges the dominant theoretical model of autism spectrum disorders
January 16, 2019 - GoFundMe CEO: ‘Gigantic Gaps’ In Health System Showing Up In Crowdfunding
January 16, 2019 - Induced neuronal cells derived from fibroblasts are similar to neurons in the brain
January 16, 2019 - New study finds link between childhood abuse and suicide in later life
January 16, 2019 - Lifestyle and health factors that are good for the heart can also prevent diabetes
January 16, 2019 - Scientists take another step in understanding bacteria that cause Salmonella epidemic
January 16, 2019 - Look to Your Aunts, Uncles and Parents for Clues to Your Longevity
January 16, 2019 - Study finds ADHD drugs are unlikely to cause cardiac damage in children who take them
January 16, 2019 - Call The Midwife! (If The Doctor Doesn’t Object)
January 16, 2019 - Changes in hippocampal structural connectivity differentiate responders of electroconvulsive therapy
January 16, 2019 - Study sheds light on the deadly venom of Mojave rattlesnakes
January 16, 2019 - University of Nebraska to develop new drugs that prevent and counteract effects of radiation exposure
January 16, 2019 - Sugar-based stent makes precarious sewing process easier
January 16, 2019 - FDA-approved drug hampers cancer metastasis in animal model, shows study
January 16, 2019 - Low-level cannabis use can change the adolescent brain
January 16, 2019 - MTC in Rouen acquires Robocath’s R-One robot for future healthcare practitioner training
January 16, 2019 - OSSIO granted FDA 510(k) market clearance for OSSIOfiber Bone Pin Family
January 16, 2019 - Childhood body composition may play a role in future respiratory health
January 16, 2019 - Outdated commissioning methods are failing mental health services in the UK, reveals report
January 16, 2019 - Unconventional immune cells trigger disturbed cytokine production in human spondyloarthritis
January 16, 2019 - Patients Turn To GoFundMe When Money And Hope Run Out
January 16, 2019 - Researchers develop novel viral identification method
January 16, 2019 - Study proposes improvements in pharmacological study of cognitive function enhancers in schizophrenia
January 16, 2019 - Study points to potential new biomarker and drug target for amyotrophic lateral sclerosis
January 16, 2019 - Differences in geographic origin of genes may affect mitochondrial function
January 16, 2019 - Study analyzes vaccine-preventable infections in children who receive solid organ transplants
January 16, 2019 - MiRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen
January 16, 2019 - Scientists uncover why knee joint injury leads to osteoarthritis
January 16, 2019 - Salk team uses new model to study health effects of AMP-activated protein kinase
January 16, 2019 - Research reveals novel approach to suppressing chemotherapy-induced tumor growth
January 16, 2019 - Researchers reveal how fasting leads to better overall health
January 16, 2019 - Deprivation and neglect in early childhood have impact on cognitive functioning in adolescence, shows study
January 16, 2019 - Training Students to use Imaging Techniques: NMR and EPR
January 16, 2019 - Nerve transfer surgery restores arm movement in children with acute flaccid myelitis
January 16, 2019 - Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
January 16, 2019 - DNA vaccine reduces both toxic proteins linked to Alzheimer’s
January 16, 2019 - Even in the U.S., poor women often can't afford tampons, pads
January 16, 2019 - One time use of Marijuana could affect teen brains finds study
January 16, 2019 - Persistent Opioid Use High in Head, Neck Cancer Patients
January 16, 2019 - Questions to ask your doctor about post pregnancy care: MedlinePlus Medical Encyclopedia
January 16, 2019 - Neurons with good housekeeping are protected from Alzheimer’s
January 16, 2019 - Is mindfulness worthy of all the hype?
January 16, 2019 - Physical Activity, Any Type or Amount, Cuts Health Risk from Sitting
January 16, 2019 - New understanding in the evolution of human feet
January 15, 2019 - AHA: New Cholesterol Guidelines Put Ethnicity in the Spotlight
January 15, 2019 - Different brain areas linked to smoking and drinking
January 15, 2019 - Henry Marsh shares insights into neurosurgery and more at Dean’s Lecture Series
January 15, 2019 - Want to Live Longer? For Just 30 Minutes a Day, Do Anything Else But Sit
January 15, 2019 - The Current issue of “The view from here” is concerned with Targets
January 15, 2019 - Plain packaging sparked tobacco price rises, new study finds
January 15, 2019 - Sedentary lifestyles can be unhealthy, physical activity can lower risk
January 15, 2019 - Gut microbiome may help prevent development of cow’s milk allergy
January 15, 2019 - Lesbian, gay and bisexual individuals more likely to suffer severe substance use disorders
January 15, 2019 - New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder
January 15, 2019 - Levels of inflammatory marker (CRP) linked to housing type and tenure
January 15, 2019 - Three gifts I’m glad I gave myself in 2018
January 15, 2019 - Columbia’s Pediatrics Department Names New Vice Chairs, Expands Leadership
The latest ECG device from Schiller

The latest ECG device from Schiller

image_pdfDownload PDFimage_print

With the launch of CARDIOVIT AT-102 G2, SCHILLER is releasing the latest generation of ECG devices.  

In the CARDIOVIT AT-102 G2 we have implemented our many years of experience, customer wishes and optimization possibilities. Our developers have used the latest and best technologies. The device makes a quantum leap in electrocardiography in one fell swoop“.

Dr. Michela Perrini, Global Product Manager at SCHILLER in Baar, Switzerland

The first 300 units CARDIOVIT AT-102 G2 have already been shipped. The decision makers of Mehiläinen in Finland reveal the devices key qualities they wanted to adopt in their nationwide institution.

The Swiss medical engineering company SCHILLER launches the latest generation in electrocardiography for hospitals, clinics and medical practices.

CARDIOVIT AT-102 G2 features state of-the-art technology, extremely high operation speed, ease of use, and bi-directional WiFi communication to implement the patient data and send the ECG.

The CARDIOVIT AT-102 G2 is equipped with an 8-inch HD colour display for quick and effective ECG review. The screen has touch function keys, which, together with the navigation keys, allow a very fast device operation.

Simplifying the daily clinic life

The sophisticated hardware and software make CARDIOVIT AT-102 G2 very fast. The device’s internal memory can accommodate several hundred ECGs. If a record is to be transmitted to an EPA / HIS/ PACS system by WiFi, this can be done in less than a second.

This task is what appreciates one of the first customers that bought five units of CARDIOVIT AT-102 G2: Mehiläinen, a nationwide provider of healthcare services in Finland.

Finnish national recommendations are going to DICOM ECG. So we are updating our ecg process as well as archiving systems. Our long, good and reliable cooperation and experience with SCHILLER systems and devices gave faith in continuity.”

Kristina Hotakainen, Director of laboratory services at Mehiläinen Oy

CARDIOVIT AT-102 G2 will be connected with the Mehiläinen Carestream PACS system through the new SCHILLER SEMA.

“The automated DICOM workflow is easy and needs a minimum of manual entries,” said Matti Pekka Räsänen, Mehiläinen IT Service Engineer

Fast reliable connectivity in the new workflow with minimum manual work in data recording was an important feature for the Mehiläinen decision makers. Paperless fast recording is easy and effective for the Mehiläinen laboratories and occupational nurses.

High speed for greatest efficiency

“In particular, the very fast and very simple operation was a main customer requirement. With CARDIOVIT AT-102 G2, we were able to bring today’s state of the art into medical technology – not an easy task, but we succeeded,” says Dr. Michela Perrini, Global Product Manager at SCHILLER.

Using only one navigation key and in three short steps, it is possible to download the patient data via PDQ or work list, to record the ECG, and then to save, print and transmit the data. The device supports paperless workflows, which saves costs.

When a paper report is needed, custom printouts can be made from the internal full sized (A4), high-resolution thermal printer. The long battery life makes a single battery charge sufficient for eight hours of ECG recordings during the labour-intensive clinical routine. In addition, CARDIOVIT AT-102 G2 is robust and reliable.

The alphanumeric keyboard is sealed and easy to clean, making it easier to comply with the strict hospital hygiene requirements. The trolley’s smoothly running wheels and a handle at the optimum height allows comfortable moving and working. With the standardly mounted storage basket, all important accessories are always at hand.

Proven SCHILLER quality

With its latest innovation, SCHILLER has developed an impressive ECG device with many new features that far exceed the high requirements in the healthcare sector. The body illustration on the large screen shows the exact electrode placement for different configurations. A new function indicates when electrodes have been connected incorrectly.

CARDIOVIT AT-102 G2 has highest signal quality, which is especially important for paediatric ECGs. The automatic interpretation provides a reliable analysis of the ECG for both children and adults.

Three software options complete CARDIOVIT AT-102 G2: Stress ECG, ETM Sport for the automatic interpretation of the athlete’s heart and CCAA (Culprit Coronary Artery Algorithm).

From a one-man operation to the world’s leading ECG supplier

Company founder Alfred Schiller started his company with ECG devices in the 1970s. To date, a variety of device types have been developed.

SCHILLER is one of the world’s leading developers and suppliers of cardiac diagnostics. Currently, more than a dozen ECG devices are available, with special features depending on customer needs, location or the desired accessories.

CARDIOVIT AT-102 G2 is the latest electrocardiography product. It is CE approved. The CARDIOVIT AT-102 G2 is produced at the SCHILLER headquarters in Baar, Switzerland.

Tagged with:

About author

Related Articles